Cadence Bank Viatris Inc Transaction History

Cadence Bank

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $8,713 - $9,940	-966 Reduced 5.36%	17,064 $170,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $3,468 - $4,622	-377 Reduced 2.05%	18,030 $173,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $2,223 - $2,947	255 Added 1.4%	18,407 $204,000
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $2,230 - $2,927	263 Added 1.47%	18,152 $154,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $4,795 - $5,914	-482 Reduced 2.62%	17,889 $187,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $3,305 - $5,189	-337 Reduced 1.8%	18,371 $200,000
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $1,341 - $1,629	-111 Reduced 0.59%	18,708 $253,000
Q3 2021 Nov 10, 2021	BUY	$13.25 - $15.13 $10,825 - $12,361	817 Added 4.54%	18,819 $255,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $29,675 - $36,951	-2,288 Reduced 11.28%	18,002 $257,000
Q1 2021 May 11, 2021	SELL	$13.59 - $18.54 $10,844 - $14,794	-798 Reduced 3.78%	20,290 $284,000
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $301,558 - $395,189	21,088 New	21,088 $395,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

Stay updated on Cadence Bank with notifications on news.